SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ORTC Ortec International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: fut_trade who wrote (197)8/26/1998 1:21:00 PM
From: Gary Clarke  Read Replies (2) of 272
 
Restated earnings down. Here is what I read. Gary
In NYTH040, Genesis Initiates Coverage of Ortec International; Analyst Issues Buy with 18-month $28 Price Target, moved earlier today, we are advised by a representative for the company that the first graph, last sentence should read "Tihansky forecasts a loss of $1.11 per share for fiscal 1998." rather than "Tihansky forecasts fiscal 1998 earnings at $1.11 per share." as originally issued.

-0- 07/02/98 C NYTH040
/PRNewswire -- July 2/
/Web site: sternco.com
(ORTC)

CO: Ortec International; Genesis Merchant Group Securities
ST: California
IN: MTC FIN CPR
SU: RTG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext